海外の治験の状況「HPV」での検索結果
29件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A comparative study looking at the prevalence of human papilloma virus (HPV) and HPV types in term and preterm labour cases by testing placentae, high vaginal swabs and maternal blood (cfDNA) (HIPPOP trial).
- Preterm labour (PTL);Premature preterm rupture of membranes (PPROM);Human Papilloma Virus (HPV)
- New Zealand
- 2018-02-21
Not Recruiting
- Determination of the human papillomavirus (HPV)-specific antibody status in oral fluids of individuals vaccinated with a quadrivalent HPV vaccine
- Healthy women aged 18-26 MedDRA version: 9.1 Level: LLT Classification code 10065136 Term: Human papilloma virus exposure
- Austria
- 2009-02-09
Not recruiting
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial
- Anogenital Human Papillomavirus Infection;Condyloma Anal;Anogenital Human Papillomavirus Infection;Condyloma Anal;Anogenital Human Papillomavirus Infection;Condyloma Anal
- Austria
- 2017-09-19
Not recruiting
- Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
- Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection
- Brazil, Canada, Chile, Colombia, Denmark, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Norway, Peru, Puerto Rico, Sweden, Taiwan, Thailand, United States
- 2007-10-12
Not recruiting
- Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
- Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection
- Australia, New Zealand
- 2007-08-22
Not Recruiting
- A RANDOMIZED, INTERNATIONAL, DOUBLE-BLINDED (WITH IN-HOUSE BLINDING), CONTROLLED WITH GARDASIL™, DOSE-RANGING, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY STUDY OF A MULTIVALENT HUMAN PAPILLOMAVIRUS (HPV) L1 VIRUS-LIKE PARTICLE (VLP) VACCINE ADMINISTERED TO 16- TO 26-YEAR-OLD WOMEN
- -B977 Papillomavirus as the cause of diseases classified to other chapters Papillomavirus as the cause of diseases classified to other chapters;Papillomavirus as the cause of diseases classified to other chapters
- Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Germany, Japan, Korea South, Mexico, New Zealand, Norway, Peru, Sweden, Taiwan, Thailand, United States
- 2014-03-24
Not Recruiting
- A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus- Like Particle (VLP) Vaccine (V504) Administered Concomitantly with GARDASIL™ to 16- to 26-Year-Old Women
- Prevention of cervical, vulvar, and vaginal cancers and related precancers, external genital lesions, and persistent infection caused by Human Papillomavirus (HPV) 6, 11, 16, 18, 31, 33, 45, 52, and 58 via concomitant administration of GARDASIL™ with prophylactic 5-valent HPV (Types 31, 33, 45, 52, 58) L1 virus-like particle (VLP) vaccine2. MedDRA version: 9.1 Level: LLT Classification code 10063001 Term: Human papilloma virus infection
- Austria, Sweden
- 2007-09-12
Authorised
- Imiquimod therapy after surgical removal of anal HPV-lesions to reduce likelihood of recurrence
- anal HPV-lesions;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Austria
- 2018-01-11
Recruiting
- Feasibility of a human papilloma virus (HPV) self-sampling for cervical screening in Maori women in West Auckland
- Cervical screening;Human papilloma virus;Self-sampling
- New Zealand
- 2016-10-10
Not recruiting
- A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
- Cervical Cancers;Vulvar Cancer;Vaginal Cancer;Genital Lesions;PAP Test Abnormalities;HPV Infections;Cervical Cancers;Vulvar Cancer;Vaginal Cancer;Genital Lesions;PAP Test Abnormalities;HPV Infections;Cervical Cancers;Vulvar Cancer;Vaginal Cancer;Genital Lesions;PAP Test Abnormalities;HPV Infections;Cervical Cancers;Vulvar Cancer;Vaginal Cancer;Genital Lesions;PAP Test Abnormalities;HPV Infections
- Austria, Belgium, Brazil, Chile, Colombia, Costa Rica, Finland, India, Korea, Republic of, Peru, Poland, South Africa, Spain, Sweden, Taiwan, Thailand, United States
- 2009-07-21